1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ASTAXANTHIN MARKET BY APPLICATION
5.1. Introduction
5.2. Nutraceutical and Pharmaceutical
5.3. Food & beverages
5.4. Others
6. ASTAXANTHIN MARKET BY FORM
6.1. Introduction
6.2. Liquid
6.3. Powder
6.4. Others
7. ASTAXANTHIN MARKET BY END-USER
7.1. Introduction
7.2. Individuals
7.3. Industry
8. ASTAXANTHIN MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
10. COMPANY PROFILES
10.1. Merck KGaA, Darmstadt
10.2. DaVinci Laboratories
10.3. Arkure Health Care
10.4. Lifecare Neuro Products Limited
10.5. Moglix Labs Private Limited
10.6. BodyFirst Wellness Nutrition
10.7. Näck
10.8. Valensa International
10.9. Lessonia
10.10. AstaReal